Company Filing History:
Years Active: 2016-2023
Title: Innovations by Inventor Stephanie Byrum
Introduction
Stephanie Byrum, an accomplished inventor from Little Rock, AR, has made significant contributions to the field of cancer research. With a remarkable portfolio of six patents, her innovations focus on predicting cancer responsiveness to immunotherapeutic agents and identifying critical biomarkers in cancer treatment.
Latest Patents
Stephanie's latest patents include groundbreaking inventions such as:
1. **Methods for predicting responsiveness of a cancer to an immunotherapeutic agent and methods of treating cancer** - This invention relates to the use of histone H3 lysine (27) trimethylation (H3K27me3), E-cadherin, and other biomarkers to assess the responsiveness of a cancer tumor to immunotherapy.
2. **Methods and kits for isolation and analysis of a chromatin region** - This patent covers methods for identifying proteins and protein modifications specifically associated with chromatin, which is crucial for understanding gene expression and cancer mechanisms.
Career Highlights
Throughout her career, Stephanie has contributed to prominent organizations such as the University of Arkansas and Bioventures, LLC. Her work has not only advanced scientific knowledge in cancer treatment but has also paved the way for innovative therapeutic strategies.
Collaborations
Alongside her impressive accomplishments, Stephanie has collaborated with notable professionals in the field, including Alan J Tackett and Sean D Taverna. These partnerships have enabled her to further enhance her research and contribute to impactful developments in cancer therapies.
Conclusion
Stephanie Byrum exemplifies the spirit of innovation within the scientific community. Her dedication to improving cancer treatment through her patents illustrates her commitment to advancing medical science. With a strong foundation of collaborations and significant research, she continues to be a pivotal figure in her field.